Search fresh public links, source activity, and ready-to-use post angles for Daraxonrasib.
Fresh curated links around daraxonrasib are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Could Daraxonrasib Become the Most Expensive Cancer Drug Ever? Anonymous (not verified) Tue, 06/02/2026 - 14:43 pharmagather item url Could Daraxonrasib Be...
Revolution Medicines, Daraxonrasib, and the New Race to Drug KRAS Cancer For decades, one of the most important cancer targets was also one of the most frustrating. Scientists knew...
Kura Oncology has published early data on darlifarnib in combination with Bristol Myers Squibb’s Krazati, linking the drug candidate to response rates of up to 69% when given with...
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
CHICAGO — The eagerly awaited full dataset from arguably the most pivotal pancreatic cancer trial in decades is now public.Based on the buzz it created among ASCO Annual Meeting at...
Roche’s investigational KRAS G12C inhibitor has beaten Amgen’s Lumakras and Bristol Myers Squibb’s Krazati in a phase 3 trial, furthering its ambitions to establish divarasib as a...
New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.